OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

查看量	下载量

相关文章
更多...

化学进展 2014

基于环糊精的靶向药物传递系统

DOI: 10.7536/PC131127, PP. 1039-1049

韩彬,廖霞俐,杨波

Keywords: 环糊精,靶向药物传递系统,受体,靶向配体

Full-Text Cite this paper Add to My Lib

Abstract:

癌症等恶性增殖疾病的靶向治疗有赖于靶向药物传递系统（targeteddrugdeliverysystem，TDDS）的开发。环糊精具有低毒、易修饰等优良性质，并可通过与药物分子形成包合物而提高药物的溶解性、稳定性、安全性和生物利用度等，因而具有成为优秀药物载体的潜力。环糊精不仅可以以其本身或修饰环糊精的形式充当载体，还可通过聚轮烷、阳离子聚合物或纳米粒等形式构建有效的药物载体。肿瘤或人体某些病变部位的细胞表面存在过度表达的生物受体如叶酸受体、去唾液酸糖蛋白受体、透明质酸受体、转铁蛋白受体和整合素受体等，可以与其相应的配体产生特异性识别。用适当的化学方法将配体分子如叶酸、单糖或寡糖、透明质酸、转铁蛋白及RGD肽等键接在基于环糊精的载体上，可形成具有靶向性质的药物载体，进而与药物分子一起构筑靶向药物传递系统。这种药物传递系统不仅针对于化学治疗药物，在核酸传递中也得到了丰富的应用。本文综述了基于环糊精的靶向药物传递系统的靶向机理及最新研究进展，并对其发展前景作了展望。

References

[1]	Yague E, Raguz S. Brit. J. Cancer, 2005, 93: 973.
[2]	陈湧(Chen Y), 刘育(Liu Y). 有机化学(Chinese Journal of Organic Chemistry), 2012, 32: 805.
[3]	Loftsson T, Duchene D. Int. J. Pharm., 2007, 329: 1.
[4]	Szejtli J. Chem. Rev., 1998, 98: 1743.
[5]	Freudenberg K, Cramer F, Plieninger H. DE 895769, 1953.
[6]	Chen Y, Liu Y. Chem. Soc. Rev., 2010, 39: 495.
[7]	Bilensoy E. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications. New Jersey: John Wiley, 2011.
[8]	Chordiya M A, Senthilkumaran K. J. Pharm. Pharmacol., 2012, 1: 19.
[9]	Hwang S J, Bellocq N C, Davis M E. Bioconju. Chem., 2001, 12: 280.
[10]	Flourie B, Molis C, Achour L, Dupas H, Hatat C, Rambaud C J. J. Nutr., 1993, 123: 676.
[11]	Hirayama F, Minami K, Uekama K. J. Pharm. Pharmacol., 1996, 48: 27.
[12]	Uekama K, Minami K, Hirayama F. J. Med. Chem., 1997, 40: 2755.
[13]	El-Kamel A H, Abdel-Aziz A A M, Fatani A J, El-Subbagh H I. Int. J. Pharm., 2008, 358: 248.
[14]	Leamon C P, Reddy J A. Adv. Drug. Deliv. Rev., 2004, 56: 1127.
[15]	Sabharanjak S, Mayor S. Adv. Drug. Deliv. Rev., 2004, 56: 1099.
[16]	Chen C, Ke J Y, Zhou E X, Yi W, Brunzelle J S, Li J, Yong E L, Xu E H, Melcher K. Nature, 2013, 500: 486.
[17]	Sudimack J, Lee R J. Adv. Drug. Deliv. Rev., 2000, 41: 147.
[18]	Leamon C P, Deprince R B, Hendren R W. Drug Target, 1999, 7: 157.
[19]	刘育(Liu Y), 杨洋(Yang Y), 张瀛溟(Zhang Y M). CN 102258788B, 2012.
[20]	赖春丽(Lai C L), 赖乐(Lai L), 赵建彬(Zhao J B), 陈建海(Chen J H). 药学学报(Acta Pharmaceutica Sinica), 2010, 45: 920.
[21]	Zhou Y, Wang H, Wang C X, Li Y S, Lu W F, Chen S F, Luo J D, Jiang Y N, Chen J H. Mol. Pharm., 2012, 9: 1067.
[22]	Zhao F, Yin H, Zhang Z X, Li J. Biomacromolecules, 2013, 14: 476.
[23]	Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H. Bioconju. Chem., 2013, 24: 724.
[24]	Fallon R J, Schwartz A L. Adv. Drug. Deliv. Rev., 1989, 4: 49.
[25]	Donati I, Gamini A, Vetere A, Campa C, Paoletti S. Biomacromolecules, 2002, 3: 805.
[26]	吴卫(Wu W), 程怡(Cheng Y), 吴琼(Wu Q). 南京医科大学学报(Acta Universitatis Medicinalis Nanjing), 2012, 32:168.
[27]	Aruffo A, Stamenkovic I, Melnick M, Underhill C B, Seed B. Cell, 1990, 61: 1303.
[28]	Naor D, Sionov R V, Ish-Shalom D. Adv. Cancer Res., 1997, 71: 241.
[29]	Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. Crit. Rev. Clin. Lab. Sci., 2002, 39: 527.
[30]	Peach R J, Hollenbaygh D, Stamenkovic I, Aruffo A. J. Cell. Biol., 1993, 122: 257.
[31]	Oh E J, Park K, Kin K S, Kim J, Yang J A, Kong J H, Lee M Y, Hoffman A S, Hahn S K. J. Control. Release, 2010, 141: 2.
[32]	Luo Y, Prestwich G D. Biocunju. Chem., 1999, 10: 755.
[33]	Luo Y, Ziebell M R, Prestwich G D. Biomacromolecules, 2000, 1: 208.
[34]	Banzato A, Bobisse S, Rondina M, Renier D, Bettella F, Esposito G, Quintieri L, Meléndez-Alafort L, Mazzi U, Zanovello P, Rosato A. Clin. Cancer Res., 2008, 14: 3598.
[35]	Galer C E, Sano D S, Ghosh S C, Hah J H, Auzenne E, Hamir A N, Myers J N, Klostergaard J. Oral Oncol., 2011, 47: 1039.
[36]	Li J, Huang P, Chang L, Long X, Dong A, Liu J, Chu L, Hu F, Liu J, Deng L. Macromol. Res., 2013, 21, 1331.
[37]	Montagner I M, Banzato A, Zuccolotto G, Renier D, Campisi M, Bassi P F, Zanovello P, Rosato A. Urol. Oncol. Semin. Ori., 2013, 31: 1261.
[38]	Tsai S W, Yu D S, Tsao S W, Hsu F Y. Int. J. Nanomed., 2012, 8: 2399.
[39]	Li S D, Howell S B. Mol. Pharm., 2010, 7: 280.
[40]	Yang X, Dogan I, Pannala V R, Kootala S, Hilborn J, Ossipov D. Polym. Chem., 2013, 4: 4621.
[41]	Charlot A, Auzély-Velty R. Macromolecules, 2007, 40: 9555.
[42]	刘育(Liu Y), 杨洋(Yang Y), 张瀛溟(Zhang Y M). CN 102698286A, 2012.
[43]	Simes S, Slepushkin V, Gaspar R, de Lima M C P, Düzgüne N. Gene Therapy, 1998, 5: 955.
[44]	Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M, Yanagie H. Pharmaceut. Res., 2001, 18: 1042.
[45]	Kursa M, Walker G F, Roesler V, Ogris M, Roedl W, Kircheis R, Wagner E. Bioconju. Chem., 2003, 14: 222.
[46]	叶树楠(Ye S N), 杨述华(Yang S H), 吴强(Wu Q),杨操(Yang C), 李进(Li J), 许伟华(Xu W H). 肿瘤(Tumor), 2005, 25: 321.
[47]	Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, Shinohara A, Eriguchi M, Yanagie H, Maruyama K. Int. J. Pharm., 2008, 346: 143.
[48]	Hong M, Zhu S, Jiang Y, Tang G, Pei Y. J. Control. Release, 2009, 133: 96.
[49]	Davis M E. Mol. Pharm., 2009, 6: 659.
[50]	Heidel J D, Yu Z, Liu J Y, Rele S M, Liang Y, Zeidan R K, Kornbrust D J, Davis M E. Proc. Natl. Acad. Sci. U.S.A., 2007, 104: 5715.
[51]	Bartlett D W, Davis M E. Bioconju. Chem., 2007, 18: 456.
[52]	Pun S H, Tack F, Bellocq N C, Cheng J, Grubbs B H, Jensen G S, Davis M E, Brewster M, Janicot M, Janssens B, Floren W, Bakker A. Canc. Biol. Ther., 2004, 3: 641.
[53]	Garanger E, Boturyn D, Dumy P. Anticancer Agents Med. Chem., 2007, 7: 552.
[54]	Quan C Y, Chen J X, Wang H Y, Li C, Chang C, Zhang X Z, Zhuo R X. J. Am. Chem. Soc., 2010, 4: 4211.
[55]	Tran N Q, Joung Y K, Lih E, Park K M, Park K D. Macromol. Res., 2011, 19: 300.
[56]	Miao Q H, Li S P, Han S Y, Wang Z, Wu Y, Nie G J. J. Nanopart. Res., 2012, 14: 1043.
[57]	Seo J H, Kakinoki S, Inoue Y, Yamaoka T, Ishihara K, Yui N. J. Am. Chem. Soc., 2013, 135: 5513.
[58]	吴镁春(Wu M C), 王驰(Wang C). 中国新药杂志(Chinese Journal of New Drugs), 2010, 19: 569.
[59]	Paliwal S R, Paliwal R, Agarawal G P, Vyas S P. Crit. Rev. Ther. Drug. Carr. Sys., 2012, 29: 421.
[60]	Maruta F, Parker A L, Fisher K D, Hallissey M T, Ismail T, Rowlands D C, Chandler L A, Kerr D J, Seymour L W. Cancer Gene Ther., 2002, 9: 543.
[61]	Ng K K, Lovell J F, Zheng G. Acc. Chem. Res., 2011, 44: 1105.
[62]	Kader A, Pater A. J. Control. Release, 2002, 80: 29.
[63]	Tan S Y, Grimes S. Singap. Med. J., 2010, 51: 842.
[64]	闫真芳(Yan Z F), 徐希明(Xu X M), 余江男(Yu J N). 药物生物技术(Pharmaceutical Biotechnology), 2009, 16: 481.
[65]	Wang J, Cao Y P, Sun B G, Wang C T. Food Chem., 2011, 127: 1680.
[66]	孙涛(Sun T), 李建业(Li J Y), 郝爱友(Hao A Y). 有机化学(Chinese Journal Organic Chemistry), 2012, 32: 2054.
[67]	D’Souza V T, Bender M L. Acc. Chem. Res., 1987, 20: 146.
[68]	Garcia-Lopez J J, Hemandez-Mateo F, Isac-Garcia L, Kim J M, Roy R, Santoyo-Gonzalez F, Vargas-Berenguel A. J. Org. Chem., 1999, 64: 522.
[69]	张莉(Zhang L), 潘俊(Pan J), 陆伟跃(Lu Y W). 国外医药:合成药、生化药、制剂分册(World Pharmacy),2002, 23(6): 359.
[70]	Leamon C P, Cooper S R, Hardee G E. Bioconju. Chem., 2003, 14: 738.
[71]	Clementi A, Aversa M C, Corsaro C, Spooren J, Stancanelli R, O’Connor C, McNamara M, Mazzaglia A. J. Incl. Phenom. Macrocycl. Chem., 2011, 69: 321.
[72]	Salmaso S, Semenzato A, Caliceti P, Hoebeke J, Sonvico F, Dubernet C, Couvreur P. Bioconju. Chem., 2004, 15: 997.
[73]	Yin J J, Sharma S, Shumyak S P, Wang Z X, Zhou Z W, Zhang Y D, Guo P X, Li C Z, Kanwar J R, Yang T X, Mohapatra S S, Liu W Q, Duan W, Wang J C, Li Q, Zhang X J, Tan J, Jia L, Liang J, Wei M Q, Li X T, Zhou S F. PLoS One, 2013, 8: e62289.
[74]	Yang Y, Zhang Y M, Chen Y, Zhao D, Chen J T, Liu Y. Chem. Eur. J., 2012, 18: 4208.
[75]	Wu J, Nantz M H, Zern M A. Front. Biosci., 2002, 7: d717.
[76]	Stockert R J. Physiol. Rev., 1995, 75: 591.
[77]	Hattori K, Kenmoku, Mizuguchi T, Ikeda D, Mizuno M, Inazu T. J. Incl. Phenom. Macrocycl. Chem., 2006, 56: 9.
[78]	Yasuda N, Aoki N, Abe H, Hattori K. Chem. Lett., 2000, 3: 706.
[79]	Pun S H, Bellocq N C, Liu A J, Jensen G, Machemer T, Quijano E, Schluep T, Wen S F, Engler H, Heidel J, Davis M E. Bioconju. Chem., 2004, 15: 831.
[80]	雒琪(Luo Q), 钱皓(Qian H), 王凤山(Wang F S). 中国生化药物杂志(Chinese Journal of Biochemical Pharmaceutics), 2008, 29: 359.
[81]	Tsai S W, Yu D S, Tsao S W, Hsu F Y. Int. J. Nanomed., 2013, 8: 2399.
[82]	Dong Z, Zheng W, Xu Z, Yin Z. J. Appl. Polym. Sci., 2013, 130: 927.
[83]	Di Meo D, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V. Biomacromolecules, 2007, 8: 552.
[84]	Charlot A, Heyraud A, Guenot P, Rinaudo M, Auzély-Velty R. Biomacromolecules, 2006, 7: 907.
[85]	Yang Y, Zhang Y M, Chen Y, Chen J T, Liu Y. J. Med. Chem., 2013, 56: 9725.
[86]	杨媛(Yang Y), 娄琨(Lou K), 梅兴国(Mei X G), 吕万良(Lv W L). 中国药学杂志(Chinese Pharmaceutical Journal), 2009, 44: 1761.
[87]	蒋新国(Jiang X G). 复旦学报(医学版)(Fudan University Journal of Medical Sciences), 2012, 39: 441.
[88]	姜嫣嫣(Jiang Y Y), 裴元英(Pei Y Y). 第六届中国药学会学术年会论文集(Proceeding of the 6th Annual Conference of Chinese Pharmaceutical Association). 北京: 中国药学会(Beijing: Chinese Pharmaceutical Association), 2006. 3797.
[89]	Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y. J. Control. Release, 2010, 141: 22.
[90]	Nie Y, Schaffert D, Rdl W, Ogris M, Wagner E, Günther M. J. Control. Release, 2011, 152: 127.
[91]	Li Y, He H, Jia X, Lu W L, Lou J, Wei Y. Biomaterials, 2012, 33: 3899.
[92]	Tros de Ilarduya C, Düezgüene ??塂 N. Expert Opin. Drug Del., 2013, 10: 1583.
[93]	Hu-Lieskovan S, Heidel J D, Bartlett D W, Davis M E, Triche T J. Cancer Res., 2005, 65: 8984.
[94]	Bellocq N C, Pun S H, Jensen G S, Davis M E. Bioconju. Chem., 2003, 14: 1122.
[95]	Brahmamdam P, Watanabe E, Unsinger J, Chang K C, Schierding W, Hoekzema A S, Zhou T T, McDonough J S, Holemon H, Heidel J D, Coopersmith C M, McDunn J E, Hotchkiss R S. Shock, 2009, 32: 131.
[96]	安莲效(An L X), 李慧(Li H), 顾月清(Gu Y Q). 中国生化药物杂志(Chinese Journal of Biochemical Pharmaceutics), 2010, 31: 66.
[97]	Shukla J, Sharma U, Kar R, Varma I K, Juyal S, Jagannathan N R, Bandopadhyaya G P. Nanomedicine, 2009, 4: 895.
[98]	Hu Y P, Tang G P, Liu J, Cheng W X, Yue Y, Li J C, Zhang P. J. Biomed. Biotechnol., 2012, 989235.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133